preliminari studi immunotherapeut approach treatment human myeloma chimer antibodi multipl myeloma diseas convent chemotherapi limit valu ideal treatment passiv antibodi suitabl cell surfac antigen neoplast plasma cell antigen present major neoplast plasma cell detail examin bone marrow aspir patient strong express cell criteria light-scatt profil possess cytoplasm Ig plasma cell vast major neoplast plasma cell cell line model antigen target chimer antibodi antibodi chimer antibodi fab portion mous monoclon antibodi stabl thioether bond Fc molecul human fab-human Fc contrast parent antibodi chimer molecul antibody-depend cellular cytotox adcc human blood mononuclear effector cell effect low concentr antigen present natur killer cell littl deleteri action antibodi effector cell function antibodi growth progenitor cell granulocyte/macrophag erythroid lineag normal bone marrow suspicion cell antigen other advantag molecul serum patient myeloma vitro fourteen patient florid myeloma variou chemotherapeut regim undiminish capac adcc chimer antibodi normal individu mainten adcc activ known suppress antibodi respons patient auger treatment chimer antibodi 